The most dangerous lies are often the ones people desperately want to believe, and few corporate scandals illustrate that better than the story told in *The Inventor: Out for Blood in Silicon Valley*. Director Alex Gibney’s documentary examines the spectacular rise and fall of Elizabeth Holmes, the founder of Theranos, whose promises of revolutionary blood-testing technology captivated investors, business leaders, and the media. It’s a fascinating story of ambition, deception, and misplaced trust, and one that practically begs to be turned into a documentary. Fortunately, there’s plenty here to hold your attention, even if the film doesn’t quite do the subject justice. One of the documentary’s greatest strengths is its portrayal of Holmes herself. With her carefully cultivated public image, deep voice, black turtlenecks, and almost messianic confidence, she emerges as a compelling figure whose charisma proved remarkably effective at winning over influential people. Gibney does a good job illustrating how Holmes sold not just a product, but a vision of the future, making skepticism seem almost like a failure of imagination. It’s an insightful look at the mechanics of persuasion and the unsettling ease with which confidence can be mistaken for competence. The film also benefits from its investigative storytelling, which sometimes gives the documentary the feel of a corporate thriller. The gradual exposure of Theranos’s fraudulent claims is genuinely suspenseful, even when the subject matter threatens to become technical or dry. There’s a theatrical quality to the presentation, including some rather cheesy visual effects, but the approach generally keeps things entertaining. Those embellishments can occasionally feel unnecessary, distracting from a story that is already extraordinary enough without the cinematic dressing. More importantly, *The Inventor: Out for Blood in Silicon Valley* offers a cautionary tale about Silicon Valley’s culture of hype, excessive ambition, and promises that outrun reality. The documentary exposes an environment where the appearance of innovation can become more valuable than the actual product, while investors and powerful supporters seem all too willing to suspend disbelief when the pitch is sufficiently seductive. Holmes may be the central figure, but the broader indictment is of a system that rewards audacity while too often neglecting accountability. There are plenty of lessons here about blind faith, institutional groupthink, and the dangers of confusing a compelling vision with a proven achievement. Unfortunately, the film’s weaknesses become increasingly apparent as it moves through the scandal. The pacing occasionally drags, and the documentary devotes so much attention to Theranos’s rise and the gradual discovery of its deception that the company’s downfall feels strangely ignored. The collapse is every bit as compelling as the buildup, yet much of it receives comparatively little attention. The result is an uneven narrative that spends considerable time establishing how Holmes captivated the world but far less time examining the full consequences of that deception. Even more frustrating is the documentary’s reluctance to dig beneath the surface. How did so many intelligent, influential people fall for the scheme? How did Theranos continue operating for so long despite its technological shortcomings? And what role did Holmes’s relationship with the company’s Chief Operating Officer play in the larger story? These questions are either insufficiently explored or left unanswered. The film introduces an extraordinary web of ambition, loyalty, and deception without fully untangling it, leaving the impression that an enormous amount of fascinating material has been omitted. Holmes herself remains an equally elusive subject. Gibney presents her charisma, ambition, and capacity for deception, but stops short of probing the psychology behind them. Did she knowingly fabricate a vision she understood to be false, or did she become so consumed by her own mythology that she began believing it? What drove her beyond the desire for success? The documentary never offers a particularly satisfying examination of these questions. Its failure to interview victims or investors who lost money also diminishes its emotional impact, keeping the focus on the spectacle of the scandal rather than the people who suffered because of it. Ultimately, *The Inventor: Out for Blood in Silicon Valley* is a compelling and often entertaining documentary that tells a remarkable story with the urgency of a thriller, but mistakes an absorbing account of the deception for a complete examination of its consequences. Its abrupt ending only reinforces that sense of incompleteness; the film could have benefited from a more thoughtful conclusion that connected the scandal’s human costs to its broader lessons. There’s enough investigative substance here to make it worthwhile, and the story itself is undeniably gripping. However, a deeper exploration of Holmes, a fuller account of Theranos’s collapse, and greater attention to those affected would have made this a far more incisive documentary. A fascinating cautionary tale, but an incomplete one.